Skip to main content
Clinical Trials/NCT04764929
NCT04764929
Terminated
Not Applicable

Helmet CPAP for Infants and Pediatric Patients With Acute Respiratory Distress

Columbia University1 site in 1 country5 target enrollmentAugust 7, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Bronchiolitis, Viral
Sponsor
Columbia University
Enrollment
5
Locations
1
Primary Endpoint
Number of Participants Who Tolerated CPAP Helmet for at Least Four Hours
Status
Terminated
Last Updated
last year

Overview

Brief Summary

This a research study to find out whether giving Continuous Positive Airway Pressure (CPAP) through a Helmet is the same or better than giving CPAP through a Facemask, Nasal Mask, or Nasal Prongs. CPAP can help kids with lung infections breathe easier. The machine delivers pressurized air, which may help people with lung infections breathe more easily. Doctors routinely use a Facemask, Nasal Mask or Nasal Prongs to give CPAP for kids with lung infections, but the researchers want to know whether using Helmet CPAP is the same or better.

Detailed Description

Prior clinical trials have demonstrated efficacy of Helmet CPAP in adults with acute respiratory distress syndrome, superior tolerance and improved respiratory scores compared to nasal/facial CPAP in infants, and no major safety concerns were identified with the use of helmet CPAP. This is a prospective pilot study to (1) determine if infants and pediatric patients requiring CPAP in the PICU will tolerate helmet CPAP for at least four hours, and (2) measure changes in the respiratory rate, oxygen saturation, heart rate and blood pressure over four hours. If helmet CPAP is found to be well tolerated in this small cohort, a larger study comparing it directly to other CPAP interfaces will be conducted.

Registry
clinicaltrials.gov
Start Date
August 7, 2021
End Date
June 14, 2023
Last Updated
last year
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • One month to 5 years of age (inclusive) admitted to the PICU with community acquired pneumonia or bronchiolitis, having been stable on nasal or facemask CPAP for at least four hours but less than 48 hours, and parental informed consent.

Exclusion Criteria

  • Age less than 1 month or greater than 5 years
  • Positive for COVID-19
  • Need for invasive mechanical ventilation or higher levels of non-invasive ventilation such as bi-level positive airway pressure (BPAP)
  • Unresponsiveness (GCS 8 or less)
  • Hypotension as defined as a systolic blood pressure less than 5th percentile for age
  • Existing head or neck trauma, known or suspected air leak syndrome (pneumothorax, pneumomediastinum, subcutaneous emphysema), known or suspected increased intracranial pressure
  • Non-English speaking parent

Outcomes

Primary Outcomes

Number of Participants Who Tolerated CPAP Helmet for at Least Four Hours

Time Frame: Four hours

Tolerance is defined as the successful application and maintenance of helmet CPAP without any unplanned, prolonged (\>5 minutes) removals or disruptions.

Secondary Outcomes

  • Oxygen Saturation(4 hours)
  • Respiratory Rate(4 hours)
  • Heart Rate(4 hours)
  • Systolic Blood Pressure(4 hours)

Study Sites (1)

Loading locations...

Similar Trials